
Type 2 diabetes zzso is a worldwide epidemic with considerable health and economic zzso Diabetes is an important risk factor for cardiovascular disease, which is the leading cause of death in diabetic patients, and decreasing the zzso of diabetes may potentially reduce the burden of cardiovascular zzso This article discusses the clinical trial evidence for zzso associated with a reduction in the risk of zzso diabetes, with a focus on the role of zzso agents that block the zzso zzso zzso interventions and the use of zzso zzso and zzso drugs are also zzso An unresolved question is whether decreasing the zzso of zzso diabetes with zzso or zzso intervention will also lower the risk of cardiovascular zzso A large ongoing study is investigating whether the treatment with an oral zzso drug or an zzso blocker will reduce the zzso of zzso diabetes and cardiovascular disease in patients at high risk for developing zzso 

